Quantbot Technologies’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Quantbot Technologies’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-506	Closed	-$110K	–	2065
2023 Q2	$110K	Buy	+506	New	+$108K	0.01%	1153
2023 Q1	–	Sell	-250	Closed	-$49.1K	–	2181
2022 Q4	$49.1K	Sell	250 -6,571	-96%	-$1.41M	﹤0.01%	1309
2022 Q3	$1.53M	Buy	+6,821	New	+$1.38M	0.12%	268
2022 Q1	–	Sell	-100	Closed	-$13K	–	2155
2021 Q4	$13K	Sell	100 -500	-83%	-$64.6K	﹤0.01%	1292
2021 Q3	$73K	Sell	600 -200	-25%	-$23.1K	0.01%	1039
2021 Q2	$91K	Buy	+800	New	+$93.5K	0.01%	940
2020 Q4	–	Sell	-100	Closed	-$7K	–	1774
2020 Q3	$7K	Buy	+100	New	+$8.52K	﹤0.01%	1156

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

General Atlantic New York $2.48B AUM 19.88% 1-Year Est. Return

Quantbot Technologies's KRTX Position: Q3 2023 in Review

Quantbot Technologies sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 506 shares — an estimated $110K sold.

Quantbot Technologies first reported a position in KRTX in Q3 2020 and held it in 7 quarters. The position peaked at $1.53M in Q3 2022. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

Quantbot Technologies reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Quantbot Technologies sold 506 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $110K.
Quantbot Technologies first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Quantbot Technologies's Karuna Therapeutics, Inc. Common Stock position peaked at $1.53M in Q3 2022.
256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Quantbot Technologies's 13F filing for Q3 2023, filed 7 Nov 2023.